Publications

New method for detection of Mycobacterium tuberculosis Direct Test inhibitors in clinical specimens.

Sloutsky A, Han LL, Werner BG.

Fri, 10/01/2004 - 12:00

Diagn Microbiol Infect Dis

http://www.ncbi.nlm.nih.gov/pubmed/15474319

The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.

Rengarajan J, Sassetti CM, Naroditskaya V, Sloutsky A, Bloom BR, Rubin EJ.

Thu, 07/01/2004 - 12:00

Mol Microbiol

http://www.ncbi.nlm.nih.gov/pubmed/15225321

Practical strategies for performance optimization of the enhanced gen-probe amplified mycobacterium tuberculosis direct test.

Sloutsky A, Han LL, Werner BG.

Thu, 04/01/2004 - 12:00

J Clin Microbiol

http://www.ncbi.nlm.nih.gov/pubmed/15071002

Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru.

Mukherjee JS, Joseph JK, Rich ML, Shin SS, Furin JJ, Seung KJ, Sloutsky A, Socci AR, Vanderwarker C, Vasquez L, Palacios E, Guerra D, Viru FA, Farmer P, Del Castillo HE.

Tue, 07/01/2003 - 12:00

Int J Tuberc Lung Dis

http://www.ncbi.nlm.nih.gov/pubmed/12870684

Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods.

Madison B, Robinson-Dunn B, George I, Gross W, Lipman H, Metchock B, Sloutsky A, Washabaugh G, Mazurek G, Ridderhof J.

Fri, 11/01/2002 - 12:00

J Clin Microbiol

http://www.ncbi.nlm.nih.gov/pubmed/12409361

Multicenter evaluation of a nonweekend reading schedule for radiometric pyrazinamide susceptibility testing of Mycobacterium tuberculosis.

Madison B, Gross W, George I, Sloutsky A, Washabaugh G, Robinson-Dunn B, Lipman H, Metchock B, Mazurek G, Ridderhof J.

Tue, 10/01/2002 - 12:00

J Clin Microbiol

http://www.ncbi.nlm.nih.gov/pubmed/12354876

Novel mycobacterium related to Mycobacterium triplex as a cause of cervical lymphadenitis.

Hazra R, Floyd MM, Sloutsky A, Husson RN.

Sun, 04/01/2001 - 12:00

J Clin Microbiol

http://www.ncbi.nlm.nih.gov/pubmed/11283032

Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.

Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE.

Tue, 02/01/2000 - 12:00

Int J Tuberc Lung Dis

http://www.ncbi.nlm.nih.gov/pubmed/10694087

Enhancing Career Paths for Tomorrow's Radiation Oncologists.

Vapiwala N, Thomas CR, Grover S, Yap ML, Mitin T, Shulman LN, Gospodarowicz MK, Longo J, Petereit DG, Ennis RD, Hayman JA, Rodin D, Buchsbaum JC, Vikram B, Abdel-Wahab M, Epstein AH, Okunieff P, Goldwein J, Kupelian P, Weidhaas JB, Tucker MA, Boice JD, Fuller CD, Thompson RF, Trister AD, Formenti SC, Barcellos-Hoff MH, Jones J, Dharmarajan KV, Zietman AL, Coleman CN.

Wed, 05/22/2019 - 12:00

Int J Radiat Oncol Biol Phys

http://www.ncbi.nlm.nih.gov/pubmed/31128144

Developing a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research and Policy.

Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, Geiger AM.

Thu, 05/16/2019 - 12:00

J Natl Cancer Inst

http://www.ncbi.nlm.nih.gov/pubmed/31095326